NCT01010217
- Conditions
- Anemia, Anemia, Aplastic, Blood Protein Disorders, +38 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
448 public trials
58 recruiting studies
Hematologic Diseases trial results
NCT01445561
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00001715
- Conditions
- Hematologic Disease, Hematologic Diseases, Hemic and Lymphatic Diseases
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
NCT01201811
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Changhua Christian Hospital Changhua, Taiwan
- Chiayi Chang Gung Memorial Hospital Chiayi City, Taiwan
- Buddhist Tzu Chi General Hospital-Hualien Tzu Chi Medical Center Hualien City, Taiwan
- Kaohsiung Medical Hospital University Kaohsiung City, Taiwan
NCT00213239
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Neoplasms
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
NCT03250845
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Secondary Immune Deficiency
- Locations
-
- UZ Leuven Gasthuisberg Leuven, Vlaams-Brabant, Belgium
NCT03611257
- Conditions
- Bacteremia, Bacteremia Sepsis, Bacterial Infections, +9 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT02292446
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
- Locations
-
- Novartis Investigative Site Linz, Austria
- Novartis Investigative Site Salzburg, Austria
- Novartis Investigative Site Wels, Austria
- Novartis Investigative Site Antwerp, Belgium
Completed
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005327
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +15 more
- Locations
-
Not specified
NCT03875352
- Conditions
- Haematologic Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia